Moderna says FDA to review its flu vaccine after reversing course

The U.S. Food and Drug Administration has reversed an earlier decision and said it will review drugmaker Moderna's application for approval of a seasonal flu vaccine, the company said in a statement Wednesday. The FDA's Center for Biologics Evaluation and Research notified Moderna that the agency…